DiscovertouchPODCASTContinuous glucose monitoring for cardiovascular risk reduction: The next frontier in preventive care
Continuous glucose monitoring for cardiovascular risk reduction: The next frontier in preventive care

Continuous glucose monitoring for cardiovascular risk reduction: The next frontier in preventive care

Update: 2025-08-20
Share

Description

touchEXPERT FOCUS for touchCARDIO and touchENDOCRINOLOGY


Listen to two experts discuss how continuous glucose monitoring (CGM) can help identify and manage cardiovascular risk in people with or without diabetes. They explore the role of glycaemic variability, the limitations of conventional glucose metrics, and the added value of CGM, including recent advances and patient education to support effective use.


The experts:



  • Dr Eden Miller, Diabetes and Obesity Care, Bend, OR, USA

  • Dr Ian J Neeland, Case Western Reserve University, and Harrington Heart and Vascular Institute, University Hospitals Cleveland, OH, USA


This activity is for HCPs outside of the UK.


This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc.


This activity is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider.




For further information visit our website: www.touchCARDIO.com and www.touchENDOCRINOLOGY.com

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Continuous glucose monitoring for cardiovascular risk reduction: The next frontier in preventive care

Continuous glucose monitoring for cardiovascular risk reduction: The next frontier in preventive care

touchpodcast